IP Library Granted Patent US 7,406,963
Granted Patent B2
US 7,406,963 · App. 11/332,977 · Granted Aug 5, 2008

Variable resistance pulmonary ventilation bypass valve and method

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,406,963
App. No.
11/332,977
Granted
Aug 5, 2008
Kind
B2
Abstract

A collateral ventilation bypass trap system directly linked with a patient's lung or lungs may be utilized to increase the expiratory flow from the diseased lung or lungs, thereby treating one aspect of chronic obstructive pulmonary disease. The system includes a trap, a filter/one-way valve, an air carrying conduit and a retention device for securing system elements in position. The system also includes a flow restriction device for controlling the flow of air through the air carrying conduit.

Claims (39)

1. A flow control valve assembly for a collateral ventilation bypass system, comprising:

at least one implantable device adapted to be connected, at a predetermined site, to at least one lung for removing trapped gases from the lung, the at least one implantable device comprising at least one conduit having first and second ends, the first end being adapted for extending into the at least one lung at a predetermined location and the second end being adapted to be positioned outside of the lung and respiratory tract of the patient, and a sealing device for establishing an airtight seal between the first end of the conduit and the lung; and

a valve assembly at least partially positioned within the at least one conduit for adjusting the flow of gases from the at least one lung through the at least one device thereby creating temporary pressure buildup in the at least one lung.

2. The flow control valve assembly according to claim 1 , wherein the valve assembly comprises an iris valve assembly.

3. The flow control valve assembly according to claim 1 , wherein the valve assembly comprises a duckbill valve assembly.

4. The flow control valve assembly according to claim 1 , wherein the valve assembly comprises a one-way flap valve assembly.

5. The flap control valve assembly according to claim 1 , wherein the valve assembly is configured for manual operation.

6. The flow control valve assembly according to claim 1 , wherein the valve assembly is configured for automatic operation.

7. A ventilation bypass system for treating a lung of a patient comprising:

a conduit adapted to pass through an artificial opening in a visceral membrane of a lung such that a proximal end of the conduit is external to the lung of the patient, a distal end of the conduit is inside the lung of the patient, and air present in the lung of the patient may exit the lung via the conduit;

a seal being adapted around the artificial opening in the visceral membrane to prevent air from entering a pleural space around the lung at the artificial opening; and

an adjustable valve assembly connected to the conduit which is adapted to adjustably restrict the exit of air from the lung through the conduit.

8. The ventilation bypass system of claim 7 , wherein the valve assembly comprises an iris valve assembly.

9. The ventilation bypass system of claim 7 , wherein the valve assembly comprises a duckbill valve assembly.

10. The ventilation bypass system of claim 7 , wherein the valve assembly comprises a one-way flap valve assembly.

11. The ventilation bypass system of claim 7 , wherein the valve assembly is configured for manual operation.

12. The ventilation bypass system of claim 7 , wherein the valve assembly is configured for automatic operation.

13. The ventilation bypass system of claim 7 , wherein the valve assembly comprises:

a sensor to assess a condition of the patient and generate an output in response to the condition; and

a valve actuator which operates the valve to restrict the flow of air through the conduit in response to the output of the sensor.

14. The ventilation bypass system of claim 9 , wherein the valve assembly comprises:

a switch adapted to be operated by the patient; and

a valve actuator which operates the valve to restrict the flow of air through the conduit in response to the switch.

15. The ventilation bypass system of claim 7 , wherein the valve assembly is adapted to temporarily block the flow of air through the conduit.

16. A method of controlling air flow in a ventilation bypass system, wherein the method comprises:

(a) implanting a conduit through an artificial opening in the visceral membrane of a lung such that a proximal end of the conduit is external to the lung of the patient, a distal end of the conduit is embedded within the lung of the patient, and air present in the lung of the patient exits the lung via the conduit;

(b) creating a seal around the artificial opening in the visceral membrane to prevent air from entering a pleural space around the lung from the artificial opening in the visceral membrane; and

(c) providing an adjustable valve assembly connected to the conduit which is adapted to adjustably restrict the exit of air from the lung through the conduit whereby actuating the adjustable valve assembly temporarily restricts the exit of air from the lung through the conduit.

17. The method of claim 16 , further comprising:

(d) providing a control system which automatically actuates the adjustable valve assembly to temporarily restrict the exit of air from the lung through the conduit.

18. The method of claim 16 , further comprising:

(d 1 ) assessing a condition of the patient with a sensor and generating an output in response to the condition; and

(d 2 ) actuating the adjustable valve assembly to temporarily restrict the exit of air from the lung through the conduit in response to the output of the sensor.

19. The method of claim 16 , further comprising:

(d 1 ) assessing a condition of the patient with an airflow sensor and generating an output in response to airflow; and

(d 2 ) actuating the adjustable valve assembly to temporarily restrict the exit of air from the lung through the conduit in response to the output of the airflow sensor.

20. The method of claim 16 , further comprising:

(d 1 ) assessing a condition of the patient with an air pressure sensor and generating an output in response to air pressure; and

(d 2 ) actuating the adjustable valve assembly to temporarily restrict the exit of air from the lung through the conduit in response to the output of the air pressure sensor.

Assignments (3)
CHANGE OF NAME Recorded Dec 3, 2007
From: RESPIRA, INC.
To: PORTAERO, INC.
Reel/Frame 020186/0043 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 28, 2007
From: NITINOL DEVELOPMENT CORPORATION
To: RESPIRA, INC.
Reel/Frame 019489/0689 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 2, 2007
From: CHANG, ASIA; TANAKA, DON AKIRA
To: NITINOL DEVELOPMENT CORPORATION
Reel/Frame 018703/0934 →